PPARA and ischemia: Additionally, by activating PPAR-α, PEA therapy prevented the expression of phosphorylated Jun kinase and NF-κB, thereby inhibiting cellular apoptosis, ischemia-induced cerebral damage, and neurobehavioral alterations[55].